Podcasts about Richmond

We're now up to 15 winners this season - so the pressure is on for Ryan Blaney and Martin Truex, Jr. as we head to Richmond. We discuss the latest NASCAR News and the Championship picture, then make our picks for Sunday!The Rundown:- Michigan: Kevin Harvick wins, and makes the NASCAR playoffs a lot more interesting- Michigan Ratings- Surprise finishers - why is Bubba so upset?- NASCAR Standings- NASCAR News:- Petty GMS picks their next driver- Charters are worth more than ever- Driver and Sponsor News- Richmond! Our Paint Scheme Preview and PicksFind the latest episodes at InTheDraftShow.com, follow on Twitter and Instagram @InTheDraftShow – and like the show on Facebook at facebook.com/InTheDraftShowThanks for listening!

Adam Cheek and Bryan Davis Keith break down NASCAR's upcoming weekend at Richmond.

This week, we're joined by Kit Rudd, a pancreatic cancer survivor who was originally from Texas and now lives in Richmond, VA. Kit is a rockstar survivor who is geared towards helping others through a variety of fundraisers that mainly focus on cycling and competitive cooking! In this episode, Kit details his journey from symptoms to present-day. He also tells some interesting stories dating back before his symptoms including the time he had the pleasure of flying Alex Trebek during his days as an Air Force Pilot. Through familial & friendship connections and a number of other threads including his own name, Kit has had ties to pancreatic cancer since long before he began his personal battle. And today he is extremely dedicated to fighting back against this disease - even while undergoing treatment with FOLFIRINOX. If you're interested in helping Kit fundraise for Project Purple, you can buy a Pancannibals cycling jersey here: https://www.journeymans.co/kits-pancannibals-fundraising-club-jersey.html To follow along with Kit's journey, follow him on Instagram and on Facebook at these links: https://www.instagram.com/cookinupacure https://www.facebook.com/kit.rudd.5 To learn more about Project Purple, visit https://www.projectpurple.org/ or follow us on social media at these links: https://www.facebook.com/Run4ProjectPurple https://www.instagram.com/projectpurple/ https://twitter.com/Run4Purple https://www.youtube.com/channel/UCgA8nVhUY6_MLj5z3rnDQZQ

Virginia Democratic Senator Tim Kaine joins Major this week to discuss the FBI search at Mar-a-Lago, Democrats' prospects this fall and the political impact of the Supreme Court's abortion decision. Plus, Kaine weighs in on whether his former running mate might give it another go in 2024. Major is on assignment in West Palm Beach, FL. Kaine is in Richmond, VA. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode of Our American Stories, Edgar Allen Poe is known for his scary short stories and poems, and when we look at his life, early tragedies explain a lot of his stories… but what we don't often think of when we consider Poe are his comedic writings, his detective stories, and even… a bit of early Science Fiction. Chris Semtner, Curator at the Poe Museum in Richmond, Virginia pulls back the curtain on Poe. Support the show (https://www.ouramericanstories.com/donate)See omnystudio.com/listener for privacy information.

Sunday's Federated Auto Parts 400 at Richmond will be a big deviation from recent races. How does that alter our approach to building quality FanDuel lineups? numberFire's Jim Sannes previews the race, discussing optimal strategies, which data we should emphasize, and the top drivers in each salary tier prior to practice and qualifying.

Chris Pennell's DraftKings NASCAR DFS picks for the Federated Auto Parts 400 at Richmond Raceway (Sunday 8/14/22). Get ONE FREE MONTH of Stokastic+ Platinum and up to a $100 deposit match bonus with PrizePicks when you sign up and make a deposit at PrizePicks http://awese.moe/PrizePicksPlatinumSHOW INDEX0:00 Federated Auto Parts 400 DraftKings NASCAR DFS Picks1:01 Track Strategy2:01 Brad Keselowski2:55 Kevin Harvick3:52 $100 First Deposit Match at PrizePicks4:32 Christopher Bell5:40 Martin Truex Jr.7:20 Denny Hamlin8:29 Federated Auto Parts 400 DraftKings NASCAR PicksEarn money by referring friends and promoting Stokastic products: https://awese.moe/AffiliateSign up for a Premium Betting Picks package for Daily Best Bets from our Experts http://awese.moe/BestBetsDiscordJoin the Stokastic Email List for Daily DFS Picks, Betting Advice & Exclusive Offers: https://bit.ly/3K7ZIlbSee the Keys To NASCAR DFS Series here: https://www.youtube.com/playlist?list=PLXmjxAzKZadXhi_wQStWugkNsufCYjWNvVisit Stokastic's NASCAR Home Page: https://www.stokastic.com/nascarSub to our Stokastic Fantasy Football channel here http://awese.moe/FFSubSub to our Stokastic Best Ball channel here http://awese.moe/BBSub#NASCARDFS #NASCARDraftKingsPicks #NASCARFantasyPicks #RichmondRaceway #FederatedAutoParts400 #NASCARRichmond #DraftKings #FanDuel #FantasyNASCAR #NASCAR #NASCARRacing #Richmond #ChrisPennellStokastic's NASCAR Strategy & ToolsNASCAR Home: https://www.stokastic.com/NASCAR/How to Win At NASCAR DFS: https://www.Stokastic.com/nascar/daytona-500-nascar-dfs-primer-draftkings-fanduel-free/NASCAR Projections: https://www.Stokastic.com/nascar/nascar-projections/NASCAR Top Driver Tool: https://www.Stokastic.com/nascar/dfs-top-drivers-tool/NASCAR Ownership Projections: https://www.Stokastic.com/nascar/dfs-nascar-ownership-projections/Sign Up: http://Stokastic.com/joinFollow StokasticTwitter https://www.twitter.com/stokastic_com @Stokastic_ComInstagram https://www.instagram.com/stokastic_com/ @Stokastic_ComFacebook https://facebook.com/StokasticCom @StokasticComChris Pennell, SaberSim DFS - Daily Fantasy Sports Strategy, DGFantasy - Daily Fantasy Sports & Betting, FSi DFS - Daily Fantasy Sports Insight Advice, Sal Vetri, Mayo Media Network - Fantasy Sports & Betting, Pat Mayo NASCAR, Mayo Media NASCAR, FantasyLabs, The Action Network, DFS Army, Run Pure Sports, Run Pure NASCAR, RPS NASCAR, The Iceberg, BrandonCruzDFS, Eric Estepp, Doc's Sports Picks, Tips and Predictions, The Iceberg, NASCAR Predictions, NASCAR Predictions Today, NASCAR Picks Today, NASCAR DFS Picks Today, NASCAR Fantasy Picks, Fantasy NASCAR Picks Today, Fantasy NASCAR Live, NASCAR Fantasy Live, Live NASCAR Fantasy Picks, Fantasy NASCAR predictions, Fantasy NASCAR lineups, Best NASCAR DFS picks today, NASCAR Richmond, Richmond Raceway, NASCAR DraftKings Picks, DraftKings NASCAR DFS Picks, Federated Auto Parts 400

Climate Change, Global Warming, Changing of the Seasons, whatever it is turtle fuck boys are living the dream.  They don't even need a classic British motorcycle to make it happen, but a good tube trip wouldn't hurt their chances. 

CRASH LANDED   Electro Sax duo that lockdowned to earth. https://dailymusicspin.com/crash-landed-plans/ follow up single   **********************************************************************************************************************************************************************************************************************************************************************   NEWS REPORT   Son Knocks Over Mom's Casket at Funeral After 'Chaotic' Family Brawl A California man was arrested last weekend after a family argument at a funeral turned ugly, resulting in a mass brawl that saw the suspect allegedly hit someone with his car and knock over the casket containing the deceased. Police were called to the Rolling Hills cemetery in Richmond around 1:30 p.m. on August 6 after reports of a "chaotic altercation" involving a large family, according to a release from the Richmond Police Department. Police said that as a result of this initial incident, the suspect got into his vehicle and drove it over the cemetery's grass and gravestones before hitting another unnamed individual and the casket.  CLICK HERE TO READ REMAINING STORY------

Hear what Ryan Blaney has to say about getting into Playoff on points going into Richmond and what Denny Hamlin, Kyle Busch, and Christopher Bell have to say about Sunday's race. Plus Kevin Harvick on motivates his team at Stewart-Haas Racing.

Are you, or someone you love, dealing with personal trauma or sexual trauma from the past that is affecting your sexual pleasure today? Join Sexologist, Dr Stephanie Sigler from Evolve your Intimacy, as she chats with Dr Holly Richmond, one of North America's leading sex therapists, who helps couples and individuals with relationship and sexuality issues, including Hollywood's elite and prominent corporate clientele, as they dive deep into how to reclaim your sexual pleasure on your own terms. They talk about Dr Holly's new book, a sex positive guide for moving past sexual trauma and living a passionate life.

Chris Pennell's DraftKings NASCAR DFS picks for the Federated Auto Parts 400 at Richmond Raceway (Sunday 8/14/22). Get ONE FREE MONTH of Stokastic+ Platinum and up to a $100 deposit match bonus with PrizePicks when you sign up and make a deposit at PrizePicks http://awese.moe/PrizePicksPlatinumSHOW INDEX0:00 Federated Auto Parts 400 DraftKings NASCAR DFS Picks1:01 Track Strategy2:01 Brad Keselowski2:55 Kevin Harvick3:52 $100 First Deposit Match at PrizePicks4:32 Christopher Bell5:40 Martin Truex Jr.7:20 Denny Hamlin8:29 Federated Auto Parts 400 DraftKings NASCAR PicksEarn money by referring friends and promoting Stokastic products: https://awese.moe/AffiliateSign up for a Premium Betting Picks package for Daily Best Bets from our Experts http://awese.moe/BestBetsDiscordJoin the Stokastic Email List for Daily DFS Picks, Betting Advice & Exclusive Offers: https://bit.ly/3K7ZIlbSee the Keys To NASCAR DFS Series here: https://www.youtube.com/playlist?list=PLXmjxAzKZadXhi_wQStWugkNsufCYjWNvVisit Stokastic's NASCAR Home Page: https://www.stokastic.com/nascarSub to our Stokastic Fantasy Football channel here http://awese.moe/FFSubSub to our Stokastic Best Ball channel here http://awese.moe/BBSub#NASCARDFS #NASCARDraftKingsPicks #NASCARFantasyPicks #RichmondRaceway #FederatedAutoParts400 #NASCARRichmond #DraftKings #FanDuel #FantasyNASCAR #NASCAR #NASCARRacing #Richmond #ChrisPennellStokastic's NASCAR Strategy & ToolsNASCAR Home: https://www.stokastic.com/NASCAR/How to Win At NASCAR DFS: https://www.Stokastic.com/nascar/daytona-500-nascar-dfs-primer-draftkings-fanduel-free/NASCAR Projections: https://www.Stokastic.com/nascar/nascar-projections/NASCAR Top Driver Tool: https://www.Stokastic.com/nascar/dfs-top-drivers-tool/NASCAR Ownership Projections: https://www.Stokastic.com/nascar/dfs-nascar-ownership-projections/Sign Up: http://Stokastic.com/joinFollow StokasticTwitter https://www.twitter.com/stokastic_com @Stokastic_ComInstagram https://www.instagram.com/stokastic_com/ @Stokastic_ComFacebook https://facebook.com/StokasticCom @StokasticComChris Pennell, SaberSim DFS - Daily Fantasy Sports Strategy, DGFantasy - Daily Fantasy Sports & Betting, FSi DFS - Daily Fantasy Sports Insight Advice, Sal Vetri, Mayo Media Network - Fantasy Sports & Betting, Pat Mayo NASCAR, Mayo Media NASCAR, FantasyLabs, The Action Network, DFS Army, Run Pure Sports, Run Pure NASCAR, RPS NASCAR, The Iceberg, BrandonCruzDFS, Eric Estepp, Doc's Sports Picks, Tips and Predictions, The Iceberg, NASCAR Predictions, NASCAR Predictions Today, NASCAR Picks Today, NASCAR DFS Picks Today, NASCAR Fantasy Picks, Fantasy NASCAR Picks Today, Fantasy NASCAR Live, NASCAR Fantasy Live, Live NASCAR Fantasy Picks, Fantasy NASCAR predictions, Fantasy NASCAR lineups, Best NASCAR DFS picks today, NASCAR Richmond, Richmond Raceway, NASCAR DraftKings Picks, DraftKings NASCAR DFS Picks, Federated Auto Parts 400

The Truck N' Hustle "Reset" is Back! This time it's BIGGER in Houston, Texas! Buy Your Tickets Here: Buy Now Special thanks to our sponsors : OTR Capital “To Connect With A Reliable Factoring Partner For Your Trucking Business Needs Contact”: https://otrcapital.com/truck-n-hustle Or Call to speak with an account representative at Call 470 900 3338 GTT Commercial Tires GTT Commercial Tires is a Tire store that is designed with the owner/operator in mind. With Two conveniently located stores in Richmond and Petersburg Virginia and over 2,000 5 star Google reviews they a truly raising the bar and setting a new standard in Tire care Make sure you Call 800 991 6251 to schedule your appointment now! And tell them Truck N Hustle sent you . Exodus Dispatching and Training The Exodus Logistics Learning Center (ELLC) is an online transportation, supply chain and logistics training platform. Our goal is to provide a BASIC-level overview and understanding of the complete supply chain process. Call 757 515 1684 Website Address : https://www.exodusdispatchingandtraining.com/ Email Address : exoduslogisticsllc@yahoo.com or info@exodusdispatchingandtraining.com Xpress Technologies Grow beyond load boards and regain your independence one journey at a time. Xpress Technologies provides carriers like you with consistent and reliable freight that is tailored to meet your specific needs and preferences. Learn more at xpresstechfreight.com or download the Xpress Technologies mobile app today or Call 423 408 6863 Special thanks to our guest Jason Burns, President of the CLDA https://www.dropoff.com/ https://www.linkedin.com/in/jasongburns https://instagram.com/jgbsenior?igshid=YmMyMTA2M2Y= https://www.CLDA.org/ Jason Burns, President of the CLDA & Corporate Development Director of Dropoff Jason Burns is a passionate business leader in the Greater New Orleans community and the Same Day transportation industry. He is a native New Orleanian and a proud graduate of St. Augustine High School, receiving the distinguished “Purple Knight” Award, which is given to the best all-around student. Mr. Burns later became a student-athlete (football) at Vanderbilt University where he was a member of the SEC Honor Roll Team, selected as the recipient of the Head Coach's Dedication Award and he earned a Bachelor of Arts degree in Communication Studies in 2006. Jason later returned to his hometown to assume a leadership role in his family's business enterprises, including Burns Management Group (BMG), Global Parking Systems (GPS) and QCS Logistics (formerly Quick Courier Services, Inc). As a second-generation owner and President of QCS, Mr. Burns led the company's resurgence by developing new service offerings, implementing a new technology platform, and expanding operations into new markets. These initiatives resulted in record growth and QCS was selected to the Inc. 5000 list as one of America's fastest growing companies for four consecutive years. QCS was also recognized as a Top 100 Icon of Industry by ICIC (Initiative for a Competitive Inner City) in 2014. In 2020, QCS was acquired by Dropoff, a national same day delivery company headquartered in Austin, Tx. Mr. Burns is also the managing partner of a boutique investment firm that focuses on commercial real-estate development and private equity investments. He recently founded InPacity, a startup digital freight broker that uses proprietary technology to automatically connect less than truckload (LTL) freight shipments to the available capacity within the final mile carrier network throughout the US.

Sam Mayer is one of the brightest young stars in the Xfinity series. The Wisconsin driver just locked up his 2023 plans by signing an extension with JR Motorsports. Mayer joins Mike Bagley on this week's show to chat about 2023 and his chances in the 2022 playoffs. We also look ahead to this weekend's action as we preview the odds for the Federated Auto Parts 400 at Richmond Raceway. Learn more about your ad choices. Visit podcastchoices.com/adchoices

ALSO: Evansville explosion kills 3, damages dozens of homes... Indiana Fever try to avoid WNBA infamySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Powered by Haymaker Coffee: Promo Code: Race25 We recap The Closer getting his first win in years, Kevin Harvick wins Michigan. Is Kurt Busch cleared for Richmond?, Where is Noah Gragson driving in 2023? Plus a full Richmond Preview, and Fantasy NASCAR with Rowdy Dragon. Hosted by Kerry Murphey and Toby Christie

Concussion symptoms not completely gone Kurt Busch is sidelined again and Denny Hamlin wants him to take off all the time he needs to heal. Petty GMS picks Noah Gragson as their new driver and William Byron on making second visit to Richmond with Next Gen Cup Car.

Beer 1: Toppling Goliath, El Segundo (2:05) Virgil Ortiz Recap (7:35) Xander Zayas - we're Angel Investors in Xander stock (12:30) Teofimo Lopez - odds and thoughts (19:50) Landscape for 140lbs (26:15) NBA - Stat Muse player picks (42:35) MLB Turn 2 - Jordan is on the Mets Bandwagon (48:20) Nascar Pitstop - 6th win! Richmond picks (49:50) Parlay (52:25) Meme of the week Beer 2: Founders, El Segundo (54:35) Time Travel in movies spitball session (69:50) Better Call Saul - Season 6 Episode 12 "Waterworks" - episode break down, recap of where we've been, thoughts on how the series ends

Rosemary V. James currently resides in Richmond, Kentucky. A retired Occupational Therapist, her pride in life are her eight grandchildren. She is a proud Appalachian woman raised in Estill County, Kentucky. Rosemary began writing in 2019 after the passing of her husband, attending the Carnegie Center for Literacy and Learning in Lexington, Kentucky. Where she is currently completing the Author Academy 2021-2022, writing a socially informed memoir on child abuse and domestic violence's impact across one's lifespan. Her essay “Fly On” can be found on the online grief site opentohope.com.

Thanks also to Instacart for partnering with us! instacart.oloiyb.net/RBNP

On this week's episode we start out by taking a look back at a really solid race at Michigan, where a new but familiar winner emerged. Then it's time to move ahead to Richmond for the SECOND time this year. We talk about the significance of that, and talk about the different statistical data that we're using this week to try and find the best picks at this race track. Then we talk outright picks. A little chalky this week, and there's some explanation as to why. In the Finishing Position bet section we take more of a bigger swing with a couple guys who aren't really on the beaten path here, as well as some props that are floating around on DraftKings. Then, at the (31:40) point in the show, we welcome on our guest: Mark aka @SkyboxNascar! It's his second appearance and it's coming at a great time as he's been on fire throughout this summer. We talk how the year has been for him, what he has going on, and dig into his thoughts on Richmond, including a Full Tank Faceoff that has a "first", for that segment! Let us know how we did! GUEST: Mark aka @SkyboxNascar- 31:40

We officially have Chaos for the Playoffs! Kevin Harvick's win at Michigan jumbles everything up and (as of now) knocks Martin Truex, Jr. out of the Playoff Picture... but he's the favorite at Richmond this weekend and could get back in. On this episode of Stacking Dennys, Jordan and Nick recap the Michigan race, discuss Playoff implications, and then preview the upcoming Richmond race and all of the wild scenarios that could unfold over the new few weeks.Stacking Dennys is a NASCAR podcast featuring Jordan McAbee of Fantasy Racing Online and Nick Giffen (a.k.a. "RotoDoc") of The Action Network as the two discuss Fantasy NASCAR strategies and top bets for the upcoming race.

Episode 242! Timmy G's self imposed picking Kevin Harvick until he wins curse has been broken! Kevin Harvick gets the W in Michigan! Things are tight for the playoffs, we'll talk about the chances for Martin Truex Jr. and Ryan Blaney to make the playoffs now that there are 15 different winners! Still 3 races to go, we could get more playoff chaos with racing at Richmond! Be safe,  @Lungboy & @TimmyG @WickedFastPdcst on Twitter, @WickedFastPodcast on Insta or Like the Wicked Fast Podcast on Facebook Please join our NASCAR Fantasy League! You know you want to Subscribe on iTunes! You can also subscribe on Google Play or Spotify. Click for more info about the Wicked Fast Podcast Check out Timmy G's Celtics Podcast - Banner Banter Podcast Find more great podcasts at bPodStudios.com…The Place To Be For Podcast Discovery

On this episode of Stacking Pennies with Corey LaJoie, Corey and the crew break down all things Michigan, including Kevin Harvick securing a playoffs spot and Denny Hamlin receiving his 31st penalty of the year. Kyle Petty joins as co-host. Learn more about your ad choices. Visit podcastchoices.com/adchoices

I would love to introduce you to “Live Free Creative,” a self-development podcast for creative and adventurous people. Tune in weekly to explore tools you can use to find the freedom to live the life you really want, right now. Listen as host Miranda Anderson casually and conversationally shares experiences and lessons from her own life as an adventurous mom, maker, and the lifestyle blogger behind Live Free Creative Co. In addition, she lets you in on humorous and engaging stories about living with her husband, three kids, two dogs, two cats, and six chickens in Richmond, Virginia. apple.co/livefree Live Free Creative Learn more about your ad choices. Visit megaphone.fm/adchoices

Pastor Paul Morgan, founder of Chosen Generation Ministries in Richmond, VA, where church is not as usual. Pastor Paul guides and encourages the congregation to participate in a 2-way open dialogue; allowing openness and transparency about their Christian walk. He fosters a safe and nonjudgmental atmosphere of mutual ministry and exhortation. He also has an independent counseling ministry with over 16 years of experience in individual, marital and family counseling, as well as facilitating workshops and seminars. Phone: 866 333.9505    Email: ministermorgan77@gmail.com     Website: www.chosenrva.com WEEKLY BROADCASTS: “His Abounding Grace” Tuesdays @ 7 pm; ”Challenged To Change” Wednesdays @ 7 pm; "Declaring The Finished Work" Thursdays @ 12 Noon; "Friday Night Joy" 1st, 2nd & 4th Fridays @ 7 pm; "Bread Of Life" 1st & 3rd Sundays @ 7:00pm;  WEEKLY PRAYER:  “Mid-Day Glory Prayer”  Wednesdays @ 1:00pm - Dial-in  (267) 807-9605 Access Code: 732-499# (Listen later @ 267-807-9608 Access Code 732-499*)   MONTHLY BROADCASTS: “LifeLine" 1st Mondays @ 7pm; “Adoration” 3rd Mondays @ 7 pm; Spiritual Nuggets of Truth" 2nd & 4th Mondays @ 8 pm; “Matters of The Heart” 3rd Fridays @ 7pm; “Bold And Beautiful” 2nd Saturdays @ 10:00am; "R3 "Real Life, Real Men, Real Talk 2nd Sundays @ 7:00pm; “Marriage Takeover” 4th Sundays @ 7:00 pm        ALL TIMES EASTERN STANDARD

This is Episode 9, Season 4 of The TMI Project Podcast: Pride Stories featuring Kiebpoli Calnek and Erik Harris. Kiebpoli has always identified with male and female energies, but it isn't until they meet a trans man at a queer sex party that they begin to have the language to claim their trans identity.Erik has never been comfortable with his Triple D chest. Finally, a gender-affirming surgery allows him to shine like the sun.Kiebpoli Calnek (they/them), a non-binary queer Black creative born and raised in Lenapehoking/New York City, has generated nuanced performances and artistic direction seeped in poetic elements for over two decades.​​Erik Harris (he/him) is living his best life as a Black, queer, trans man in Richmond, VA. As an aspiring chef, he spends most of his time cooking, both at work and at home. When he isn't in the kitchen, he is lounging at the James River or playing bass guitar for his cat, Tux.This episode was written collaboratively by Eva Tenuto, Blake Pfeil, and Julie Novak, produced and edited by Eva Tenuto, and mixed and mastered by Stevie Manns. It was co-produced by Radio Kingston and sponsored in part by MrJulieTees.com.Radiokingston.orgMrJulieTees.comJulieNovak.comBlakePfeil.comtmiproject.orginstagram.com/tmiprojectfacebook.com/tmiprojecttwitter.com/tmiproject

The Hanover County school board began discussing a new draft policy around transgender facility uses; Social justice protesters have been paid more than $1 million by the City of Richmond; Sixty-six patients died in state-operated behavioral health facilities during fiscal year 2021; and other local stories.  

In this episode, Clint explains why Tupac and Biggie are no longer in his Top 5 rappers of all time.Richmond, VA 8/26Washington, D.C. 8/27Raleigh, NC 9/1https://linktr.ee/mitll

This week, please join authors John McMurray and David Cherney, editorialist Kausik Umanath, as well as Associate Editors Ian Neeland and Brendan Everett as they discuss the original research articles "Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights from DAPA-HF" and "Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition" and editorial ""Dip" in eGFR: Stay the Course With SGLT-2 Inhibition." Dr. Carolyn Lam: Welcome to Circulation On the Run, your weekly podcast summary and backstage pass to the Journal and its editors. We're your co-hosts, I'm Dr. Carolyn Lam, Associate Editor from the National Heart Centre and Duke National University of Singapore. Dr. Greg Hundley: I'm Dr. Greg Hundley, Associate Editor and director of the Pauley Heart Center at VCU Health in Richmond, Virginia. Dr. Carolyn Lam: Greg, it's the season of double features. Except this time, we're having a forum discussion of two related articles and an editorial that discusses both. What is it on? SGLT2 inhibitors. In the first paper, an analysis from the DAPA-HF trial, looking specifically at that initial dip in GFR that follows initiation of dapagliflozin in patients with HFrEF. Then we will discuss further, in a mechanistic way, the renal and vascular effects of combining SGLT2 inhibition on top of ACE inhibition. Lots and lots of good learning and insights, but let's go on first to the other papers in today's issue. Shall we? Dr. Greg Hundley: You bet, Carolyn, and I'm going to grab a cup of coffee. Carolyn, in this issue, wow, so many exciting original articles. In fact, there are two more articles that were going to pair together, both clinical and pertaining to TAVR procedures. In the first one, it was a group of authors led by Dr. Duk-Woo Park from the Asan Medical Center at the University of Ulsan College of Medicine. They conducted a multicenter, open-label randomized trial comparing edoxaban with dual antiplatelet therapy or DAPT, aspirin plus clopidogrel, in patients who had undergone successful TAVR and did not have an indication for anticoagulation. Now in this study, Carolyn, the primary endpoint was an incidence of leaflet thrombosis on four-dimensional computed tomography, CT, performed at six months after the TAVR procedure. Key secondary endpoints were the number and volume of new cerebral lesions on brain magnetic resonance imaging or MRI and the serial changes of neurological and neurocognitive function between six months and that time immediately post the TAVR procedure. Dr. Carolyn Lam: Oh, interesting. What did they find? Dr. Greg Hundley: Right, Carolyn. In patients without an indication for long-term anticoagulation after successful TAVR, the incidence of leaflet thrombosis was numerically lower with edoxaban than with dual antiplatelet therapy, but this was not statistically significant. The effect on new cerebral thromboembolism and neurological or neurocognitive function were also not different between the two groups. Now because the study was underpowered, the results should be considered really as hypothesis generating, but do highlight the need for further research. Dr. Greg Hundley: Carolyn, there's a second paper pertaining to transcatheter aortic valve prosthesis. It's led by a group directed by Dr. Paul Sorajja from the Minneapolis Heart Institute Foundation and Abbott Northwestern Hospital. Carolyn, these authors prospectively examined 565 patients with cardiac CT screening for HALT, or what we would define as hypoattenuating leaflet thickening, at 30 days following balloon-expandable and self-expanding TAVR. Now, deformation of the TAVR prosthesis, asymmetric prosthesis leaflet expansion, prosthesis sinus volumes, and commissural alignment were analyzed on the post-procedural CT. For descriptive purposes, an index of prosthesis deformation was calculated, with values greater than 1 representing relative midsegment underexpansion. A time-to-event model was also performed to evaluate the association of HALT with the clinical outcomes. Dr. Carolyn Lam: Oh, interesting. What did they find? Dr. Greg Hundley: Right, Carolyn. Nonuniform expansion of TAVR prosthesis resulting in frame deformation, asymmetric leaflet, and smaller neosinus volume was related to the occurrence of HALT in patients who underwent TAVR. What's the take home here, Carolyn? These data may have implications for both prosthesis valve design and deployment techniques to improve clinical outcomes in these patients. Now, Carolyn, both of these articles are accompanied by an editorial from Dr. Raj Makkar from the Smidt Heart Institute at Cedars-Sinai's Medical Center. It's a very lovely piece entitled Missing Pieces of the TAVR Subclinical Leaflet Thrombosis Puzzle. Well, how about we check what else is in this issue? My goodness, this was a packed issue. First, Carolyn, there are three letters to the editor from Professors Ennezat, Dweck, and then a response from Dr. Banovic pertaining to a follow-up from a previously published study, the AVATAR study, in evaluating valve replacement in asymptomatic aortic stenosis. There's also a Perspective piece from Dr. Wells entitled “Treatment of Chronic Hypertension in Pregnancy: Is It Time For A Change?” There's a Global Rounds piece from Professor Berwanger entitled “Cardiovascular Care in Brazil: Current Status, Challenges, and Opportunities.” Then there's also a Research Letter from Professor Eikelboom entitled “Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.” Dr. Carolyn Lam: There's another Research letter by Dr. Borlaug on longitudinal evolution of cardiac dysfunction in heart failure with normal natriuretic peptide levels. There's also a beautiful Cardiology News piece by Bridget Kuehn on the post-COVID return to play guidelines and how they're evolving. Well, that was a great summary of today's issue. Let's hop on to our feature forum. Shall we? Dr. Greg Hundley: You bet, Carolyn. Can't wait. Dr. Carolyn Lam: Today's feature discussion is actually a forum because we have two feature papers in today's issue. They all surround the cardiorenal interaction, should I say, of the SGLT2 inhibitors. For the first paper, discussing that initial decline or that dip in the GFR following initiation of dapagliflozin would be Dr. John McMurray, who's the corresponding author of this paper from DAPA-HF. Dr. John McMurray's from the University of Glasgow. Now next, we have also the corresponding author of another paper, really going into the mechanistic insights of the renal and vascular effects of combined SGLT2 and ACE inhibition. Dr. David Cherney is from Toronto General Hospital, University of Toronto. Dr. Carolyn Lam: We have the editorial list of these two wonderful papers, Dr. Kausik Umanath from Henry Ford Health in Michigan. Finally, our beloved associate editors, Dr. Ian Neeland from Case Western Reserve and Dr. Brendan Everett from Brigham and Women's Hospital, Harvard Medical School. Thank you, gentlemen. Now with all of that, what an exciting forum we have in front of us. Could I start by asking, of course, the respective authors to talk a little bit about your papers? I think a good place to start would be with Dr. McMurray. John, please. Dr. John McMurray: Thanks, Carolyn. I think our paper had three key messages. The early dip in eGFR that we saw was, on average, very small in patients with heart failure, about 3 mLs/min or about 5%. Very few patients had a large reduction in the eGFR. It was around 3%. Dapagliflozin-treated patients had a 30% or greater decline compared to about 1% of placebo patients. Finally, very few of those patients had a decline in the eGFR below a critical threshold, which for cardiologists might be around 20 mLs/min. We saw that in only five patients; that's 0.2% of the dapagliflozin-treated patients. Second message was that that early decline partially reverses. The nadir in our study was about 14 days. But by 60 days, on average, eGFR had increased again. Hold your nerve if you see an early decline in eGFR.   Dr. John McMurray: Maybe the most important message was that that decline in the eGFR is not associated with worse cardiovascular or renal outcomes. In fact, if anything, the opposite. If you look at the patients in the dapagliflozin group with a 10% or greater decline in eGFR, then compare it to patients who didn't have that decline, these individuals were about 27% less likely to experience the primary composite outcome of worsening heart failure and cardiovascular death. If you look at the placebo group, we saw exactly the opposite. Amongst those who had a greater than 10% decline in eGFR compared to those who didn't, those people with the early decline in eGFR were 45% more likely to experience the primary composite endpoint. The same is true for other cardiovascular outcomes for worsening kidney function. In the dapagliflozin group, decline in eGFR was not associated with more adverse events, not associated with more treatment discontinuation. That small decline in the eGFR is not a bad prognostic sign. If anything, it might be the opposite. Dr. Carolyn Lam: Thank you so much. That was really clear. David, are you going to tell us why this decline occurs? Dr. David Cherney: Yeah. Perhaps the paper that we published gives some insights into the mechanisms that are responsible for some of those changes in GFR that are thought to be acute hemodynamic effects. In the between trial, which is the trial that we published examining the effect of ACE inhibition followed by SGLT2 inhibition in patients with type 1 diabetes, we also saw that there was an expected effect of adding SGLT2 inhibition on top of an ACE inhibitor in people with uncomplicated type 1 diabetes. This acute dip in GFR was seen in this cohort of patients. We included only 30 patients in this small mechanistic study. At the same time, along with that dip in GFR, we also saw an increase in measures of proximal natriuresis. That proximal sodium loss is linked with changes in sodium handling in the kidney, which then causes changes in both probably afferent and efferent tone, which causes this dip in GFR primarily through natriuresis in this phenomenon called tubuloglomerular feedback. That was one major observation that gives insight into what we see in larger trials around the dip in GFR. Dr. David Cherney: In our mechanistic study, we also saw an additive effect on blood pressure. Blood pressure went down further with the addition of empagliflozin on top of an ACE inhibitor. In terms of the mechanisms that are responsible for the reduction in blood pressure, natriuresis certainly may be in part responsible, but we also saw a novel observation whereby there was a reduction in peripheral vascular resistance using noninvasive measures. There are likely several mechanisms that are responsible for the reduction in blood pressure. Then finally, we also saw reductions in markers of oxidative stress, which may also account for some of the effects that we see in blood pressure, as well as potentially some of the anti-inflammatory and anti-fibrotic effects that we see at least in experimental models that may have some clinical translatability to humans as well around the clinical benefits. I think the blood pressure, the renal hemodynamic effects, and some of the neurohormonal mechanisms are the major observations that we saw that may in part explain some of the really nice changes that were seen in Dr. McMurray's study. Dr. Carolyn Lam: Right. Thanks, David. But these were patients with type 1 diabetes and no heart failure. John, do you have any reflections or questions about how that may apply? By the way, what a beautiful study. Thank you, David. Dr. David Cherney: Pleasure. Thank you. Dr. John McMurray: Yes, David. I really enjoyed your study. In fact, I think, Carolyn, it does shed some insights perhaps to what's going on. As David pointed out, the reduction in peripheral arterial resistance, reduction in blood pressure, that may play some role in that early dip in eGFR as well as autoregulation in the kidney. Then the other interesting thing is that the distal nephron seems to adapt to that effect in the proximal tubule. Again, that may account for some of that recovery in eGFR, that reversal in the early dip that I spoke about, and which I think is very clinically important because, of course, physicians should make sure that they recheck eGFR if they see that early dip. Because they may find that few weeks later that that dip is much smaller and of much less concern. Dr. Carolyn Lam: Thank you, John. In fact, you're saying, stay the course, right- Dr. John McMurray: I have. Dr. Carolyn Lam: ... with the SGLT2 inhibitors. I'm actually stealing the words of the title of the editorial, a beautiful editorial by Kausik. I love that. Stay the course. Kausik, please, could you frame both papers and then with an important clinical take home message for our audience? Dr. Kausik Umanath: Sure. I think the analysis by John and his group was really relevant with the large sample size. What's impressive? Similar to a lot of these other SGLT2 studies that have come out, both in heart failure and in kidney disease progression and so on, it's remarkable how the other analysis, like the analysis of EMPA-REG and CREDENCE and so on, of similar dips. All show more or less the same magnitude, the same relative proportions of this GFR trajectory. I think the mechanistic study only highlights that though it's working with a slightly different population of type 1 patients and much earlier in their course in terms of where their GFRs are. Dr. Kausik Umanath: The other piece is that ultimately we need to understand this dip and know to monitor for it and so on. But I think the general clinician should really understand that a dip of greater than 10% really occurs in less than half the population that takes these agents. That dip, if it occurs, certainly doesn't do any harm. That said, if they see a bigger dip in the 30% range, monitor more closely and consider making sure that there aren't any other renal issues out there for that patient because they are a much smaller proportion of patients in these large trials that generate that level of dip. They should be monitored. Dr. Kausik Umanath: The other thought that we had, and thinking through this in a practical sense, is because you expect this dip, many of our cardiologists or even the nephrologists when we titrate these drugs, they're on a suite of other drugs. It's probably best to not adjust their Lasix or their loop diuretic, or their RAAS inhibitor at the same time as you're adjusting the SGLT2 inhibitor or starting it because then you may just introduce more noise into the GFR changes that you see over the next several weeks. It may be a sequential piece or at least holding those other agents constant while this gets titrated and introduced is a prudent course of action, so you don't misattribute changes. Dr. Carolyn Lam: Thanks so much. What clinically relevant points. In fact, that point about the diuretic especially applies in our heart failure world. You see the dip. Well, first, make sure the patient's not overdiuresed. Remember, there's more that the patient's taking. Thank you. That was a really great point. Brendan and Ian, I have to get you guys to share your views and questions right now. But before that, can I take a pause with you and just say, aren't you just so proud to be AEs of Circulation when we see papers like these and we just realize how incredible the data are and the clinical implications are? I just really had to say that. All right. But with that, please, what are your thoughts, Brendan? Dr. Brendan Everett: Yeah, sure. Thank you, Carolyn. Hats off to all three of our authors today for doing some amazing science. Thank you for sending it to Circulation. I think, in particular, I handled David's paper. I'm not a nephrologist and I'm probably the furthest thing from a nephrologist. Had to do my best to try and understand these concepts that I'm not sure I ever even was exposed to in medical school many years ago. I think it shows the breadth of the interest in our readership. The fact that these changes in eGFR have become a primary focus for our cardiovascular patients and that the clinical implications are really important. I guess my question, David, is... In your paper, you talked a little bit about this hypothesis of hyperfiltration and the role that hyperfiltration plays in setting patients with diabetes up for kidney disease. Is that playing a role in John's observation or not? Again, as a non-nephrologist, I have trouble connecting the dots in terms of that hypothesis and John's observation of the clinical benefit for patients that have a reduction in eGFR as opposed to no change. Dr. David Cherney: Yeah. It's a great question. It's very difficult to know with certainty in a human cohort because we can't measure the critical parameter, which is intraglomerular pressure, which we think these changes in GFR are a surrogate for. But if we go along with that train of thought, along reductions in glomerular hypertension, it very much makes sense that the patients who dip are those who have the... They're taking their medication, number one. Number two, they respond physiologically in the way that you expect them to, which is that their GFR dips at least transiently and then goes back up again through some of the compensatory mechanisms that John mentioned earlier. As was mentioned not only in this paper, but also in previous analyses from CREDENCE and previous analyses from VERTIS CV and others have shown that indeed that dip in GFR is linked with longer term renal benefits, at least. That is reflected in a reduction in the loss of kidney function over time. Dr. David Cherney: The patients who are on an SGLT2 inhibitor and those who dip by around 10% or less, those patients tend to do the best over time in terms of preserving GFR, not losing kidney function compared to patients who are on an SGLT2 inhibitor but do not dip, or those patients who actually have an increase in GFR. That is consistent with this idea that there may be a reduction in glomerular pressure, which is protective over the long term. That ties back into your question around hyperfiltration that this may indeed be due to a reduction in glomerular pressure, which is linked with risk over the long term. Dr. Carolyn Lam: Ian? Dr. Ian Neeland: I wanted to echo Brendan's comments about the excellent science. When I read these papers, it really speaks to the existential struggle that cardiologists have between kidney function and these medications that we know have cardiovascular benefits. How do we manage that practically? It's so clinically relevant, both the observation that John's paper made about the dip in the DAPA-HF trial as well as, David, your mechanistic insights. Dr. Ian Neeland: I wanted to ask John potentially about the most fascinating aspect to me of this paper was that patients with a dip of 10% or more actually ended up doing better in terms of cardiovascular outcomes, specifically hospital heart failure and hospitalizations than people on placebo with a greater than 10% dip. It speaks to the fact that... Is the physiology going on here different between those individuals whose GFR went down on placebo versus those who are on SGLT2 inhibitors? All the mechanistic insight that David's paper had in terms of blood pressure and intraglomerular pressure, how does that feedback and speak to why heart failure is strongly linked to this mechanism? We see this not just with SGLT2 inhibitors, but there are other medications now coming out showing that there's a relationship between this dip in GFR and heart failure. Can you speak to why this heart failure-kidney connection is so important and becoming greater and greater in terms of our understanding? Dr. John McMurray: Well, thank you for asking me the hardest question and one that I truly don't think I have a good answer to. I think it's obvious to all of us that the kidney is central in heart failure and perhaps cardiologists have neglected that fact, focusing more on the other organ. But by definition, almost the fluid retention that characterizes heart failure in terms of signs, and probably is the primary cause of symptoms, that clearly is a renally-mediated phenomenon. The kidney must be central to all of this. I think David right. I think the decline in eGFR that you see with this drug is simply a marker that the drug is having its physiological effect or effects. Whatever those are, they're beneficial. Clearly, patients who have an eGFR decline on placebo are different and they reflect, again, the patients that we see all the time. As our patients with heart failure deteriorate, one of the things that we commonly see, in fact becomes one of the biggest problems that we have to deal with, is that their kidney function declines. As their symptoms get worse, as their cardiac function gets worse, their kidney function also declines. Dr. John McMurray: I think you're seeing two contrasting effects here. One is the background change in eGFR, which is the placebo patients, and we've always known that that's a bad thing. Then we're seeing that early within 14 days marker of the pharmacological or physiological action of the drug. I hope you don't ask me how SGLT2 inhibitors work in heart failure. That's the other most difficult question I can think of, but I think this is just a marker of the fact that they are working. Dr. David Cherney: Yeah. Just to add to that briefly, there is this difficulty in sorting out the mechanisms that are relevant around the acute effects in the kidney that the dip in GFR reflects natriuresis that could keep patients out of heart failure; that the reduction in glomerular pressure reduces albuminuria. Albuminuria reduction is linked with kidney protection. It's linked with heart failure and ASCVD protection. Then there's also this concept of if you dip and then you stay stable afterwards, your GFR stays stable afterwards, those patients with stable kidney function that's not declining, the dippers in other words, those patients are probably able to maintain salt and water homeostasis better than someone who's declining more rapidly. All these things probably tie together in order to reflect, of course, there's a renal protective effect, but that some of those mechanisms may also tie into the heart failure mechanisms that John was mentioning. Dr. John McMurray: But, David, it's hard to imagine if we don't protect the kidney, we won't protect patients with heart failure given how fundamental, as I said, the kidney is, and how fundamentally important worsening kidney function is. Not only because it is a marker of things going badly, but also because it often results in discontinuation or reduction in dose of other life-saving treatments. To Kausik's point, it was very important about the risk of changing background life-saving disease modifying therapy. Actually, we didn't see that in DAPA-HF, which was very intriguing. There was no reduction in use of renin-angiotensin system blockers or mineralocorticoid receptor antagonists. Dr. Carolyn Lam: Thank you so much, gentlemen. Unfortunately, we are running out of time, but I would really like to ask one last question to the guests, if possible. Where do you think the field is heading? What next? What's the next most important thing we need to know? David, do you want to start? Then John, then Kausik. Dr. David Cherney: I think one of the aspects that we need to know in the future is where else can we extend these therapies into novel indications and extend the boundaries of where we currently work with these therapies. People with type 1 diabetes, for example, with either heart failure or with significant kidney disease, patients with kidney transplantation, is there a renal or cardiovascular protective effect? Then another high risk cohorts who have not been included in trials, those on immunosuppressants, for example, who were excluded from the trials. I think those are some of the areas that we need to extend into now that we understand how these therapies work in even very sick patients and that we also know that they likely have at least some benefit through suppressing inflammation, and possibly reducing infectious risks. That would provide a rationale for extending into some of these new areas. I think that's certainly, hopefully on the horizon for us. Dr. Carolyn Lam: John? Dr. John McMurray: Carolyn, obviously I think looking at post myocardial infarction population, that's an obvious place to go. There are a couple of trials there. I suppose the trial that I would love to see, and which I think would address the core question that we've been discussing today, which is: Is this all about the effect in the kidney and how important is the diuretic and natriuretic action of these drugs in heart failure? I think the key study that would address this would be doing a study in patients on dialysis. Because in those patients we could, I think, separate the issue of natriuresis, diuresis, and maybe even the dip in EGR that we've been talking about. If these drugs prove to be effective in end-stage kidney disease, patients on dialysis, that would be really fascinating. Dr. Carolyn Lam: Kausik? Dr. Kausik Umanath: That is a very interesting point. I don't know that we know necessarily outcomes, but I think from working with the DAPA-CKD, we do have a little bit of the safety data because we did continue it. I was the US MLI for that study and we did continue the SGLT2 passed into renal failure. There is a little bit of safety data there. But I don't think once you've declared an outcome, you're not collecting outcomes data after that point. That's a very interesting area to look into. Dr. Kausik Umanath: I also think the other place where this field's heading is trying to better tier and layer the multitude of agents. I think we've been waiting for about 20 to 30 years, at least in the kidney field, for something new to affect the progression of kidney disease after the ACE/ARB trials and so on. This one we've got SGLT2 inhibitors. We've got the new MRA, finerenone, and so on, which also have very beneficial cardiovascular effects. The question becomes: How do we layer these therapies? Which sequence to go in? Some of the others that are in pipeline as well that are out there that have very beneficial cardiovascular effects that may indeed also help kidney function and diabetes control, which do you go with first and so on? Dr. Carolyn Lam: Wow! Thank you so much. We really could go on forever on this topic, but it has been tremendous. Thank you once again. On behalf of Brendan, Ian, Greg, thank you so much for joining us today in the audience. You've been listening to Circulation On the Run. Don't forget to tune in again next week. Dr. Greg Hundley: This program is copyright of the American Heart Association 2022. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more, please visit ahajournals.org.

Brad Keselowski is 2/3 of the way through his first season as an owner/driver in the cup series. On this week's NASCAR Live he sits down with Mike Bagley to discuss how the year is going. We are also joined by new Richmond Raceway track president, Lori Collier Waran, ahead of this weekend's race. We also tackle Richmond from multiple angles by looking back at past 1st time winners at the track and hearing what drivers are expecting this coming weekend. Learn more about your ad choices. Visit podcastchoices.com/adchoices

If you were at Vasen in Richmond recently and you put a curse on Emily, we're onto you and our wrath is coming. Go watch the lyric video for Deadweight by Deadlock now! https://www.youtube.com/watch?v=ExkWNFs-7l0 Check out our Network Twitch channel and everything Outlaws at https://linktr.ee/outlawsnetwork Intro/Outro Music: Ethan Gustavson https://somepointsound.com Cover Art: Natalie Spitzel https://nataliespitzel.com

Richmond's esteemed triple premiership president Peggy O'Neal is a special guest on the latest episode of the Club's premier podcast Talking Tigers. Peggy recounts her fascinating journey from a small mining community in West Virginia, USA to the presidential chair at Tigerland. She talks about the board's decision to totally back coach Damien Hardwick in at the end of a disappointing 2016 season, and how that proved to be such a significant turning point for the Club. And Peggy tells why the glorious, drought-breaking 2017 Grand Final triumph over Adelaide, that followed 12 months later, is her favourite of the three Tiger flags won while she has been president. Also on this week's show, the TT team review the important Round 21 win against Port Adelaide, analyse the top-class performances of Dion Prestia, Toby Nankervis, Tom Lynch and Daniel Rioli, and discuss the blossoming Brownlow Medal prospects of Shai Bolton. If the Tigers turn you on, make sure you turn on to Talking Tigers. Click on the link to hear the latest episode.See omnystudio.com/listener for privacy information.

Welcome in everyone to another issue of The Comic Bookies Podcast. Colliding the worlds of sports and comic sis brought to you by Treasure Island Comic in Fremont, CA. Visit the shop every Wednesday, Friday and Saturday. Follow them on IG and Twitter @ticomics.  This week on the episode, seems like it's been forever since we've talked comics. So the guys let everyone know what they should or should NOT be pulling and reading. More Ezra Miller news, and no, it isn't good. And we say goodbye to a number of our beloved actors and actresses from the last few weeks.  And in sports, the MLB is in the dog days of summer, EPL is finally back with Week 1, and NASCAR is in Richmond this weekend. The NFL is also back. We get into a little HOF game, and what we can expect the rest of the offseason as we approach Week 1.  Follow us on all social media platforms @thecomicbookies. Email us at thecomicbookies@gmail.com. And subscribe to our YouTube channel to get the latest videos, shorts and live streams.  We love you all 3000!

Ep#288!! Thank you to everyone that has followed and listened! Make sure you subscribe and set to auto download! *Joey Logano makes his debut! *Jeff Striegle is back to recap MIS! *The Orange Cone and an ARCA grid walk *Social Media *Brian Neudorff has Richmond forecast *LuckyDogs, LTFantasy, & more! Itunes- https://podcasts.apple.com/us/podcast/the-lapped-traffic-podcast-nascar/id1191851979 Podbean- https://thelappedtrafficpodcast.podbean.com/ Twitter- @lappedtrafficpc Facebook- https://www.facebook.com/thelappedtrafficpodcast TikTok- @lappedtrafficpc Instagram- @lappedtrafficpc Youtube- https://www.youtube.com/channel/UCA1FcdZAt28m5yzWUP7tj2Q Website- www.thelappedtrafficpodcast.com

Richmond Police Chief shut down questions about an alleged July 4th mass shooting plot; Richmond names a new street sweeper after late Hip Hop artist; Virginia Beach high schooler wins who runs a tree-planting nonprofit wins national award; and other local stories.

This week on Bringing Intimacy Back, host Dr. April and co-host Coach Kay welcomes Tilly Storm discussing "Igniting Sexual Desire and Passion in Long-Term Relationships"! If lack of confidence, low libido, or guilt and shame around your sexuality are the cause of your bedroom woes, (the hot, wild sex you never have any more, or the transition into motherhood that sucked your libido dry), you need Tilly. She's the world's leading expert in helping women revive sexual desire and feel sexy again. As a certified sex coach, Tantra, and jade egg teacher, Tilly uses deep transformational tools and techniques based in somatic experiencing, trauma resolution and ancient tantric wisdom and Taoist practices to help women transform their blocks to pleasure, turn on, confidence and connection, helping them step into their fullest potential and power. Check her out at www.tillystorm.com The Bringing Intimacy Back Podcast is dedicated to inspire, enlighten, and encourage intimate connections. This podcast provides an engaging atmosphere to discuss ways to enhance intimacy in one's personal relationships with significant others, families, friends, Spirit, and oneself. Interested in Sponsoring the show or being featured in a review or giveaway? More information about partnerships can be found at bringingintimacyback.com/sponsorship Bringing Intimacy Back is a non-profit organization committed to inspire, enlighten and encourage intimate connections. We provide an engaging atmosphere to discuss and demonstrate ways to enhance intimacy in one's personal relationships with significant others, families, friends, spirit and self. Dr. April and Coach Kay discuss exciting topics including emotional and physical health, dating, spirituality, romance, communication and, of course, intimacy. Dr. April Brown is a Licensed Mental Health Christian Counselor in Florida, Wisconsin, New York and New Jersey. In addition, she is Certified Relationship and Sex Therapist, Board Certified TeleMental Health Counselor, National Certified Counselor, and a Qualified Clinical Supervisor. holds a Masters and a Specialist degree in Counseling and Human Systems and a Doctoral degree in Counseling Psychology. Kanya Ford, best known as Coach Kay, is the owner of Love & Intimacy 101, a life, love, and intimacy coaching practice based out of Richmond, VA. She is a life coach and certified sexologist.

God calls His people to humbly pray, seek His face, and turn from their sinful ways. Pastor Tammie Floyd teaches us that when we recognize our sin, show genuine remorse, and reverse our direction, God is waiting for us with open arms.

Get the Heart of Freedom III Replay here: https://hof3replay.thefuturegen.com/hof3recording Join the Future Generations Community here: https://community.thefuturegen.com   Remember to Rate, Review and Subscribe on iTunes and Follow us on Spotify Follow us on Instagram: @futuregenpodcast   San Diego area residents, take advantage of our special New Patient offer exclusively for podcast listeners here. We can't wait to experience miracles with you!   In this episode, Dr. Stan hears from mother Jennifer Jones, whose 8-year-old daughter was injured by the Pfizer shot. Jennifer shares not only the physical effects Riley has experienced, but the coercion, threats, and unimaginable additional stressors that she and her family have had to navigate as well. On behalf of our children, please share this episode!   Jennifer Jones is  a mom of two beautiful girls. She lives on a farm in a small town near Richmond, VA with her husband and two beautiful daughters. She enjoys taking weekend getaways with her family.   ______________________________   Stay Connected with the Future Generations Podcast:  Instagram: @futuregenpodcast, @thefuturegensd  and @drstantonhom_  Facebook: Future Generations Podcast and Future Generations | Clinic of Chiropractic  Website: Future Generations | Clinic of Chiropractic    Remember to Rate, Review and Subscribe on iTunes and Follow us on Spotify!

Damian Barrett and Josh Gabelich bring you all the latest footy news on AFL Daily Tom Lynch is in some of the best form of his career (0:00); The young forwards making their mark in 2022 (6:15); Ken Hinkley's future (9:56); Finals or bust for the Blues? (14:11); How do the Bulldogs respond from here? (17:57) Subscribe to AFL Daily and never miss an episode. Rate and review wherever you listen to podcasts.See omnystudio.com/listener for privacy information.

Host Scott Fisher opens the show with David Allen Lambert, Chief Genealogist of the New England Historic Genealogical Society and AmericanAncestors.org. David shares a story he just learned that shows how close he came to never existing! Then the guys open up Family Histoire News with the story of an adopted woman whose DNA results led her to the identity of her biological father. The question is… will she find him first or will the FBI? Hear the details of this one! Then, we have a new “Oldest Person in America!” Find out who she is and how old. Next, it's a lost and found for Viking remains. One museum had them, then lost them, and now they're found again. Find out the details. The guys then talk about a cemetery for free persons of color that has been acquired in Richmond. Catch the rest of the story. Finally… the story of the alphabet may now be complete. Hear how the final piece of the puzzle may have been found. Next, Fisher begins a two part visit with Nick DeVaux of St. Lucia. Nick's father was a World War 2 pilot for England and left his son his pilot's log book. A few years back, Nick had an idea to use that book to collect history by having history makers from the war sign the wartime heirloom. Hear the story of how it began, what he will ultimately do with the book, and some of the stories of the people who have signed it. David then returns for questions about researching ancestral businesses and why some ancestors don't appear in immigrant passenger lists. That's all this week on Extreme Genes, America's Family History Show!

What a way to cap off a return to City Stadium with a sweep of FC Tucson. A brace from the King himself and Richmond find themselves in first place in USL league 1!

Mayor London Breed has been dropping hints that the sun could possibly be setting on the city's pandemic driven "Slow Streets Program," aiming to bring the city further into a post-COVID mindset. Following an announcement that the program "needs to evolve," and a sudden restriction placed on a popular slow street in the Richmond district, many are concerned the quieter roadways could return to to their pre-COVID density.

This week, Sam McClure, Jake Niall and Greg Baum discuss the Pies, who are confounding statistics and expectations and have now won 11 in a row. Plus, why trading Dustin Martin could be the right move for Richmond, what the future might hold for Lance Franklin, a watching brief on Ken Hinkley and much more.   Got a question about your club? Send it to realfootypod@theage.com.au for our hosts to answer. Follow us on Twitter and Facebook. And if you value independent, quality journalism, please subscribe to The Age today. Thanks for listening and don't forget to check out more great podcasts from The Age & SMH.Support the show: https://subscribe.theage.com.au/See omnystudio.com/listener for privacy information.

A spike alert issued for the Richmond region; Henrico's new Recreation and Parks director is out after just three months; new affordable housing units planned as part of VCC development; Highland Springs High School's championship basketball team holds its ring ceremony; a Glen Allen all-star baseball team comes up just short in its World Series title attempt.Support the show

Christ In The Psalms / Scripture Text: Psalm 61:1-8; Matthew 23:37-39 / The Rev. Lewis Lovett

Scott Pendlebury joined us after the Pies won their eleventh game in a row! He touched on the Ed Langdon sledge, his dislocated finger which has ruined his hand modelling career, being liked across the nation in 2022, the upcoming games & the prospect of Richmond making waves in September! See omnystudio.com/listener for privacy information.

John Kenney

As a bonus for you, we're sharing a special preview of Dateline: Missing in America, an all-new original podcast series from Dateline.In this episode, Dateline's Josh Mankiewicz tells the story of Keeshae Jacobs, a 21-year-old from Richmond, Virginia, who told her mother she was spending the night at a friend's house in September of 2016. She never returned home.Subsequent episodes will also each focus on one person's story, as told by those left behind. Listen carefully to the details, descriptions and clues offered by family, friends and investigators. Something you hear might jog a memory that could help authorities crack a case.Follow Dateline: Missing in America and listen now: https://link.chtbl.com/mia_fdtw

As a bonus for you, we're sharing a special preview of Dateline: Missing in America, an all-new original podcast series from Dateline.In this episode, Dateline's Josh Mankiewicz tells the story of Keeshae Jacobs, a 21-year-old from Richmond, Virginia, who told her mother she was spending the night at a friend's house in September of 2016. She never returned home.Subsequent episodes will also each focus on one person's story, as told by those left behind. Listen carefully to the details, descriptions and clues offered by family, friends and investigators. Something you hear might jog a memory that could help authorities crack a case.Follow Dateline: Missing in America and listen now: https://link.chtbl.com/mia_fdtw